Login/Sign Up
Letfirst Tablet 5's belongs to the group of anti-cancer medicines called aromatase inhibitors used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.
Letfirst Tablet 5's contains 'Letrozole' that works by blocking the aromatase enzyme, which is involved in the production of the estrogen hormone. The cancer cells require estrogen for their growth. Hence, by blocking the aromatase enzyme, Letfirst Tablet 5's prevents the growth of cancer cells. Thereby Letfirst Tablet 5's helps in preventing or stopping the growth of spreading the tumours (cancer cells) to other body parts.
You are advised to take Letfirst Tablet 5's for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, Letfirst Tablet 5's may cause certain common side-effects such as hypercholesterolemia (increased cholesterol levels), tiredness, weakness, increased sweating, feeling unwell, pain in joints, and hot flushes (feeling of warmth). Do not be reluctant to talk with your doctor if you experience any of these side-effects persistently.
Avoid taking Letfirst Tablet 5's if you are pregnant or breastfeeding. Letfirst Tablet 5's may cause drowsiness and dizziness, so drive only if you are alert. Letfirst Tablet 5's should not be given to children as safety has not been established. Avoid consuming alcohol along with Letfirst Tablet 5's as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications to rule out any side-effects.
Letfirst Tablet 5's belongs to the group of anti-cancer medicines called aromatase inhibitors. Letfirst Tablet 5's is used to treat breast cancer in women who have gone through menopause (cessation of periods). Letfirst Tablet 5's works by blocking the aromatase enzyme, which is involved in the production of estrogens. The cancer cells require estrogen for their growth, so by blocking the enzyme Letfirst Tablet 5's prevents the growth of cancer cells. Thereby, Letfirst Tablet 5's helps in slowing down or stopping the growth and/or spreading the tumours to other body parts.
Do not take Letfirst Tablet 5's if you are allergic to any of its contents, if you have not yet gone through menopause (still get your periods). Talk to your doctor before taking Letfirst Tablet 5's if you have osteoporosis (thinning of bones), bone fractures, severe liver or kidney disease. Letfirst Tablet 5's may cause inflammation in tendons or tendon injury; contact your doctor if you observe any sign of tendon pain or swelling while taking Letfirst Tablet 5's. Avoid taking Letfirst Tablet 5's if you are pregnant or breastfeeding. Letfirst Tablet 5's may cause drowsiness and dizziness, so drive only if you are alert. Letfirst Tablet 5's should not be given to children as safety has not been established. Avoid consuming alcohol along with Letfirst Tablet 5's as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications before taking Letfirst Tablet 5's to rule out any side-effects.
Drug-Drug Interactions: Letfirst Tablet 5's may interact with antidepressants (citalopram, escitalopram) and anticancer (tamoxifen).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have high cholesterol, osteoporosis (thinning of bone), or liver disease.
Breast cancer: It is a type of cancer that develops in breast cells which are stimulated by the female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), and in the fatty tissue or the fibrous connective tissue within the breast. The tumour cells invade other healthy breast cells and can travel to lymph nodes which are a primary pathway for the cancer cells to move to other parts of the body. Symptoms of breast cancer include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.
About Letfirst Tablet 5's
Letfirst Tablet 5's belongs to the group of anti-cancer medicines called aromatase inhibitors used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.
Letfirst Tablet 5's contains 'Letrozole' that works by blocking the aromatase enzyme, which is involved in the production of the estrogen hormone. The cancer cells require estrogen for their growth. Hence, by blocking the aromatase enzyme, Letfirst Tablet 5's prevents the growth of cancer cells. Thereby Letfirst Tablet 5's helps in preventing or stopping the growth of spreading the tumours (cancer cells) to other body parts.
You are advised to take Letfirst Tablet 5's for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, Letfirst Tablet 5's may cause certain common side-effects such as hypercholesterolemia (increased cholesterol levels), tiredness, weakness, increased sweating, feeling unwell, pain in joints, and hot flushes (feeling of warmth). Do not be reluctant to talk with your doctor if you experience any of these side-effects persistently.
Avoid taking Letfirst Tablet 5's if you are pregnant or breastfeeding. Letfirst Tablet 5's may cause drowsiness and dizziness, so drive only if you are alert. Letfirst Tablet 5's should not be given to children as safety has not been established. Avoid consuming alcohol along with Letfirst Tablet 5's as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications to rule out any side-effects.
₹100*
₹85*
MRP ₹100
15% CB
₹15 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Available Offers
Country of origin
Manufacturer/Marketer address
Letfirst Tablet 5's works by blocking the aromatase enzyme, which is involved in the production of estrogens. The cancer cells require estrogen for their growth, so by blocking the enzyme Letfirst Tablet 5's prevents the growth of cancer cells. Thereby, Letfirst Tablet 5's helps in slowing down or stopping the growth and/or spreading the tumours to other body parts.
Letfirst Tablet 5's causes dizziness and drowsiness. So, drive only if you are alert and omit driving or operating machinery if you feel dizzy or drowsy.
High blood pressure could be a side-effect of Letfirst Tablet 5's. Regularly monitor blood pressure levels while taking Letfirst Tablet 5's. Consult your doctor if you regularly notice high blood pressure levels.
Do not stop taking Letfirst Tablet 5's on your own. You are advised to take Letfirst Tablet 5's for as long as your doctor has prescribed it for you depending on your medical condition. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Letfirst Tablet 5's.
Letfirst Tablet 5's may cause osteoporosis (bone thinning) due to the reduction of estrogen in the body. Regular bone density tests may help you monitor osteoporosis. Contact your doctor if you observe any sign of tendon pain or swelling while taking Letfirst Tablet 5's.
Letfirst Tablet 5's may cause weight gain due to an increase in appetite. Eat a healthy diet and exercise regularly to maintain proper weight.
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking Letfirst Tablet 5's to avoid unpleasant side effects. Alcohol intake, along with Letfirst Tablet 5's, may cause increased drowsiness.
Pregnancy
Unsafe
Letfirst Tablet 5's is pregnancy category D medicine so, should not be taken during pregnancy.
Breast Feeding
Unsafe
Letfirst Tablet 5's should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby.
Driving
Caution
Letfirst Tablet 5's may cause dizziness and drowsiness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Safe if prescribed
It is safe to take Letfirst Tablet 5's if prescribed. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Safe if prescribed
It is safe to take Letfirst Tablet 5's if prescribed. Please consult your doctor if you have kidney impairment or any concerns regarding this. No dosage adjustment is required for kidney patients with creatinine clearance greater than 10 mL/min.
Children
Unsafe
Letfirst Tablet 5's should not be used by children, as the efficacy and safety have not been established.
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Uses of Letfirst Tablet 5's
Medicinal Benefits
Letfirst Tablet 5's belongs to the group of anti-cancer medicines called aromatase inhibitors. Letfirst Tablet 5's is used to treat breast cancer in women who have gone through menopause (cessation of periods). Letfirst Tablet 5's works by blocking the aromatase enzyme, which is involved in the production of estrogens. The cancer cells require estrogen for their growth, so by blocking the enzyme Letfirst Tablet 5's prevents the growth of cancer cells. Thereby, Letfirst Tablet 5's helps in slowing down or stopping the growth and/or spreading the tumours to other body parts.
Side Effects of Letfirst Tablet 5's
Directions for Use
Storage
Drug Warnings
Do not take Letfirst Tablet 5's if you are allergic to any of its contents, if you have not yet gone through menopause (still get your periods). Talk to your doctor before taking Letfirst Tablet 5's if you have osteoporosis (thinning of bones), bone fractures, severe liver or kidney disease. Letfirst Tablet 5's may cause inflammation in tendons or tendon injury; contact your doctor if you observe any sign of tendon pain or swelling while taking Letfirst Tablet 5's. Avoid taking Letfirst Tablet 5's if you are pregnant or breastfeeding. Letfirst Tablet 5's may cause drowsiness and dizziness, so drive only if you are alert. Letfirst Tablet 5's should not be given to children as safety has not been established. Avoid consuming alcohol along with Letfirst Tablet 5's as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications before taking Letfirst Tablet 5's to rule out any side-effects.
Therapeutic Class
Drug-Drug Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Breast cancer: It is a type of cancer that develops in breast cells which are stimulated by the female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), and in the fatty tissue or the fibrous connective tissue within the breast. The tumour cells invade other healthy breast cells and can travel to lymph nodes which are a primary pathway for the cancer cells to move to other parts of the body. Symptoms of breast cancer include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.
by Others
by Others
by AYUR
by Others
by Others